White Cloud Announces 5-Year Anniversary TARPON SPRINGS,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
White Cloud Announces 5-Year Anniversary

TARPON SPRINGS, Fla., Oct. 2, 2013 (GLOBE NEWSWIRE) -- White Cloud Electronic Cigarettes is announcing its 5 th anniversary and is celebrating the milestone with a gift to their customers.

As early innovators in the e-cigarette industry, the founders of White Cloud have been focused on creating and developing high-quality, cost-effective products in addition to building their customer base and brand. In an industry poised to break the $2 billion sales threshold, e-cigarette companies are clamoring for market share and long-term customers. To that end, this 5-year old boot-strapped company is leading the space with innovative marketing tactics and competitive pricing strategies that might leave many wondering how this company can afford it. "It's a very thin line between profit and loss, and at these prices we don't make any money, but unlike our competitors who squander tens of millions on advertising, we prefer to spend our marketing budget on the folks most important to us, our customers. From the very beginning, we were able to cultivate something more akin to a fan base than a customer list; in fact nearly all of our growth can be attributed to referral sales or "word of mouth", said Matthew Steingraber, co-founder of White Cloud Cigarettes.

It is said that a rising tide lifts all boats, and the product development team at White Cloud believes they share some of the credit in creating a product worthy of the American consumer. In the early days of the industry, electronic cigarettes were highly inconsistent and product quality was abysmal. "Variability was high and customer satisfaction was low; that's an inverse relationship that can't be sustained. In the beginning, we spent a lot of capital on warranty replacements and customer retention efforts, and we believe the Company continues to reap the benefits of those defining moments," said Steingraber.  

There has been little oversight on this product segment to date, something that is likely to change in the near future. The FDA's Center for Tobacco Products recently announced that it plans to develop regulations on the marketing and manufacturing of electronic cigarettes. "Since we began as White Cloud in October 2008, we've had a laser focus on research and development, constantly refining our processes and along the way we've been figuring out how to run a business. We have developed a strategic approach to online marketing, advanced our quality control measures, and assembled a cutting-edge team of employees. We have exciting plans for the future – and we look forward to another successful year."   

To thank their loyal customers for their continued support, White Cloud is offering an anniversary sale price of 99 cents each on their new trial-size, 50-puff Fling Mini electronic cigarettes . 

In accordance with the number 5, the sale will apply to the first 500,000 Fling Minis sold.

About White Cloud Electronic Cigarettes


White Cloud Electronic Cigarettes , formed in 2008 and located in Tarpon Springs, FL, is a vertically integrated manufacturer and marketer of electronic cigarettes. The company is one of the first to produce a completely disposable electronic nicotine delivery product using lightweight food grade BPA-free thermoplastics. Its product line includes Fling Original, Fling Mini, Cirrus, ClearDraw, SmoothDraw, ShotGun Tips, ChargeBolt and Squid USB e cig charging systems. Offering over 18 flavors in up to 6 nicotine strengths, the company sells its products worldwide through its retail locations, online store, and third party retailers, wholesalers, and distributors.

Kara White, Social Media Coordinator 1-800-491-CIGS, ext. 201

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 37

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 35

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 26

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 35

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 23

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 32

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Kotak Mahindra Bank's Innovative Tech Strategies

Updated Category News Views 587

Kotak Mahindra Bank's Commitment to Digital Transformation Kotak Mahindra Bank is at the forefront of revolutionizing financial services through its innovative technology strategies. Their latest report dives deep into the bank's extensive tech activities, highlighting how it leverages digital transformation to enhance customer experience and streamline operations....

Continue Reading
Star Group, L.P. Reflects on Fiscal 2024 Performance Updates

Updated Category News Views 349

Star Group's Fiscal 2024 Insights and Performance Analysis As the fiscal year wraps up, Star Group, L.P. (NYSE: SGU), a respected home energy distributor, shares its financial performance that ended on September 30, 2024. Amidst the prevailing challenges in the energy market, the company continues its commitment to delivering quality services while adapting to market...

Continue Reading
Krystal Biotech Launches Clinical Trial for Eye Therapy KB801

Updated Category News Views 148

Krystal Biotech Begins Phase 1/2 Trial of KB801 Krystal Biotech, Inc. (NASDAQ: KRYS) has recently announced exciting developments in its ophthalmology pipeline with the initiation of a Phase 1/2 clinical trial for KB801, aimed at treating neurotrophic keratitis (NK). This 2:1 randomized, double-masked, multicenter, placebo-controlled study, named EMERALD-1, marks a...

Continue Reading
Key Updates on the Annual General Meeting of Ignitis Group

Updated Category News Views 163

Exciting Updates for the Ignitis Group Shareholders The retained earnings figure for AB “Ignitis grup?” has been amended for the upcoming Annual General Meeting. It now stands at EUR 320,319,368.41, following a revision made only to the English version of the document. This adjustment reflects the company’s commitment to transparency and accuracy in their financial...

Continue Reading
Transforming Connectivity: The Future of mmWave Sensors Growth

Updated Category News Views 104

The mmWave sensors market was set on a blistering growth path back in 2023, valued at around USD 0.25 billion. By the time you fast-forward to 2032, projections had it skyrocketing to USD 2.40 billion, boasting a staggering CAGR of 28.59% from 2024 through 2032. You'd think this kind of momentum would have traders buzzing—oh wait, they were, especially as the push for...

Continue Reading